The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Open accessAbstract
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The delivery of therapeutic RNA molecules (siRNA or microRNA) encapsulated within the lipid or lipid-like carrier231,232 into the cells or tissues was proven to be effective in infectious diseases and tumors, as shown in many preclinical studies233,234,235 and clinical trials (reviewed by Kaczmarek et al.236).”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [233]
In the citing paper
“Some other LNPs were reported with organ specificity, such as cKK-E12 lipopeptide nanoparticles, wherein the lipid tails were conjugated to peptide derivatives and achieved liver targeting siRNA delivery.[67]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Self-citationRational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“TTR, primarily synthesized in hepatocytes, plays significant roles in transporting thyroxine and retinol (10).”
BackgroundSelf-citationAbdel‐Magid, A. F., Carson, K. G., Harris, B. D., Maryanoff, C. A., & Shah, R. D. (1996) · The Journal of Organic Chemistry · doi:10.1021/jo960057x · Cited by 1,521
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Self-citationBio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,251
The promises and pitfalls of RNA-interference-based therapeutics
Castanotto, D., & Rossi, J. J. (2009) · Nature · doi:10.1038/nature07758 · Cited by 1,241
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Self-citationGenetic Heterogeneity in Human Disease
McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981
Cited by
Sorted by citations
Items 401–488 of 488
Laturski, A. E., Dulay, M. T., Perry, J. L., & DeSimone, J. M. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00028 · Cited by 6
Sato, M., Samaridou, E., Beck‐Broichsitter, M., Maeki, M., Kita, S., Tokeshi, M., Maenaka, K., Harashima, H., & Sato, Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091194 · Cited by 5
Optimizing the targeting of lipid nanoparticles for gene therapy
Yue, L., Gao, X., Qi, W., Zhang, L., & Wang, Y. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00351b · Cited by 6
Ma, P., Ma, H., Li, J., Bi, W., Zhang, S., Hou, W., & Xu, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104532 · Cited by 6
He, Z., Le, Z., Shi, Y., Liu, L., Liu, Z., & Chen, Y. (2023) · Angewandte Chemie · doi:10.1002/ange.202310401 · Cited by 5
Self-citationWang, K. C., Young, T. L., Chen, J., Tsai, S. N., Xu, Y., Varley, A., Solek, N. C., Gong, F., Lu, R. X. Z., Hubbard, B. P., et al. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.4c00081 · Cited by 6
Frich, C. K., Andersen, A. H. F., Rolskov, L. A., Zuwała, K., Gajda, P., Løvschall, K. B., Dagnæs‐Hansen, F., Banda, D. H., Pietschmann, T., Tolstrup, M., et al. (2017) · ACS Macro Letters · doi:10.1021/acsmacrolett.7b00471 · Cited by 5
Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods
Gu, R., Si, D., Lei, D., Xie, X., Li, Y., & Wen, H. (2026) · MedComm · doi:10.1002/mco2.70612 · Cited by 6
Design of peptide-based gene delivery systems to overcome biological barriers
Wang, Z., Zhou, J., Su, R., Qi, W. D., & Wang, Y. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00766f · Cited by 4
The Delivery of ABE mRNA to the Adult Murine Liver by Lipid Nanoparticles (LNPs)
Yang, D. J., & Song, C. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_12 · Cited by 4
siRNA Treatments for Diabetic Neuropathy: Obstacles and Delivery Techniques
Akhtar, M. S., Mohsin, N., Zahak, A., Ahmed, K. A. A. A., Alhazmi, Y., & Taleuzzaman, M. (2024) · Current Molecular Medicine · doi:10.2174/0115665240307413240531111140 · Cited by 5
Askarizadeh, A., Vahdat‐Lasemi, F., Karav, S., Kesharwani, P., & Sahebkar, A. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.113624 · Cited by 4
Pantatosaki, E., & Papadopoulos, G. K. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b01261 · Cited by 4
Ongun, M., Lokras, A. G., Foged, C., & Thakur, A. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_11 · Cited by 4
Strengths and Limitations of Translating the Hybrid Nanostructures to the Clinic
Thorat, N. D., Brennan, G., Bauer, J., Silien, C., & Tofail, S. A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813906-6.00012-3 · Cited by 4
Ghosh, S., Chaudhury, D., Chowdhury, A., & Jana, N. K. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-96-4959-4_4 · Cited by 3
Michalaki, E., Jeong, K., Chin, R. L., Qi, Z., Liebman, L. N., González-Vargas, Y., Echeverri, E. S., Paunovska, K., Muramatsu, H., Pardi, N., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c12080 · Cited by 8
Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies
Gholami, S., Aghbash, P. S., Ravanlo, Z. Z., Rahimi, S. B., & Baghi, H. B. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116193 · Cited by 4
Mo, Y., & Zheng, G. (2026) · ACS Nano · doi:10.1021/acsnano.6c09354 · Cited by 3
Chemical Modification and Delivery System of Small Interfering RNA Drugs★
Li, C., Si, X., Li, J., & Zhang, Y. (2023) · 化学学报 · doi:10.6023/a23040179 · Cited by 4
Self-citationIn Vivo Delivery Processes and Development Strategies of Lipid Nanoparticles
Cheng, J., Jian, L., Chen, Z., Li, Z., Yu, Y., & Wu, Y. (2024) · ChemBioChem · doi:10.1002/cbic.202400481 · Cited by 4
The time course of in vivo cellular responses to LNPs
Loughrey, D., Paunovska, K., Echeverri, E. S., Tiegreen, K. E., & Dahlman, J. E. (2025) · Chemical Communications · doi:10.1039/d4cc06659f · Cited by 3
Thakur, A., Wadhwa, A., Lokras, A. G., Müllertz, O. A. O., Christensen, D., Franzyk, H., & Foged, C. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.005 · Cited by 3
Research highlights from the International Journal of Nanomedicine 2014
Shiekh, F. A., Mian, S. H., Patel, N., Shah, F., & Arja, S. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s81085 · Cited by 3
Liu, Y., Musetti, S., & Huang, L. (2021) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc073.pub3 · Cited by 3
Nelson, B. C., & Borgos, S. E. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0024 · Cited by 3
Yuan, Z., Luozhong, S., Li, R., Gu, W., Chen, Y., Bhashyam, D., Lai, R., & Jiang, S. (2025) · ACS Nano · doi:10.1021/acsnano.5c02001 · Cited by 6
Self-citationLiu, Q., Zhang, Y., Guo, Q., Sun, J., Pan, Z., Lin, S., Fan, K., Luo, T., Li, Y., Gong, N., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502225 · Cited by 2
Self-citationNanomaterial-enabled physical rehabilitation: mechanisms, evidence, and translational pathways
Niazi, S. K. (2026) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2026.1763655 · Cited by 2
Grau, M., Kostyurina, E., Seidl, J., Martini, N., Winkeljann, B., Merkel, O. M., Rädler, J. O., & Wagner, E. (2026) · Materials Today · doi:10.1016/j.mattod.2026.103353 · Cited by 2
Hou, L., Cao, J., Gao, S., Wang, X., Zhang, Z. Q., Li, M., Mao, Y., Liu, C., Yan, L., Hao, H., et al. (2026) · Research · doi:10.34133/research.1377 · Cited by 2
Critical chemistry manufacturing and controls considerations for mRNA lipid nanoparticle translation
Liu, L., Wang, Y., Gao, H., Ruan, J., Lu, W., Liu, T., Li, X., Zhang, G., & Xiao, Y. (2026) · Discover Nano · doi:10.1186/s11671-026-04864-4 · Cited by 3
Donner, A. L. (2014) · Science-Business eXchange · doi:10.1038/scibx.2014.815 · Cited by 2
Sager, H. B., Dutta, P., Hulsmans, M., Courties, G., Sun, Y., Heidt, T., Vinegoni, C., Borodovsky, A., Fitzgerald, K. J., Wojtkiewicz, G. R., et al. (2015) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 2
Self-citationLi, B., & London, E. (2023) · Methods · doi:10.1016/j.ymeth.2023.08.015 · Cited by 2
Delivery of Cancer Nanotherapeutics
Chung, B. L., Kaplinsky, J., Langer, R., & Kamaly, N. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_8 · Cited by 2
Self-citationTargeted Combination Nanotherapeutics in Cancer a Real Promise
Shiekh, F. A., Mian, S. H., Arja, S. B., & Rao, M. R. (2015) · Nanomedicine · doi:10.2217/nnm.15.75 · Cited by 2
Gene Therapy for Liver Disease
Aravalli, R. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00060-6 · Cited by 2
Gossart, J.-B., Pascal, E., Meyer, F., Heuillard, E., Gonçalves, M., Gossé, F., Robinet, É., Frisch, B., Seguin, C., & Zuber, G. (2017) · Global Challenges · doi:10.1002/gch2.201700013 · Cited by 4
Control of Gene Expression by RNAi: A Revolution in Functional Genomics
Kumar, S., & Salar, R. K. (2017) · Springer eBooks · doi:10.1007/978-981-10-4732-9_2 · Cited by 2
Wang, D., Min, H., Wang, Z., Wang, X., Li, H., Cao, M., & Wang, J. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c01829 · Cited by 2
Multiplexed Nanomedicine for Brain Tumors: Nanosized Hercules to Tame Our Lernaean Hydra inside?
Panek, W. K., Khan, O. F., Yu, D., & Lesniak, M. S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0260 · Cited by 2
The 2024 Kavli Prize in Nanoscience: Nanomedicine
Artzi, N., Buriak, J. M., Chan, W. C. W., Chen, C., Hersam, M. C., Kim, I., Liz‐Marzán, L. M., Parak, W. J., Tian, B., & Chen, X. (2024) · ACS Nano · doi:10.1021/acsnano.4c09619 · Cited by 2
Advanced drug delivery systems for enhancing the efficacy of RNA-based therapeutics
Alhabib, N. A., Almaniea, M. A., Alehaidib, S. M., Almansour, M. A., Aldosary, M. S., Almegbel, M. T., Alsubaie, S. A., & Alzahrani, A. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15029 · Cited by 1
Microfluidic Device Type Improves Heart mRNA Delivery In Vivo
Echeverri, E. S., Kim, H., Jang, B., Shakked, A., Park, C. J., Baek, K. I., Choi, L., Kang, D. W., Hung, R.-C., Jeong, K., et al. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c02612 · Cited by 1
A two-step continuous flow synthesis of multi-tail ionizable lipids
Bozinovic, N. S., Atwood, G., MacLeod, K. C., Vincent-Rocan, J.-F., Kairouz, V., & Charette, A. B. (2025) · Chemical Communications · doi:10.1039/d5cc04692k · Cited by 1
Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview
Aranda‐Lara, L., Escudero-Castellanos, A., Trujillo-Nolasco, M., Morales-Ávila, E., Ocampo‐García, B., Oros‐Pantoja, R., Monroy, V. S., & Isaac‐Olivé, K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111408 · Cited by 1
Intratracheal administration: Non-invasive approach for liver-targeted siRNA-LNP delivery
Zong, Y., Meng, L., Wang, X., Du, L., Zheng, S., Zhang, H., Wei, T., Gao, S., & Cheng, Q. (2025) · Nano Research · doi:10.26599/nr.2025.94908267 · Cited by 1
Dyett, B., Alsaiari, S. K., Daristotle, J. L., Forster, T. A., Lau, A., Varshney, D., Afaneh, R., Hanna, A. R., Sloane, C., Mankus, D. V., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.75716 · Cited by 1
Self-citationYuen, B. P., Wong, K., Cheung, H. W., Ho, E. N. M., & Wong, W. (2026) · Journal of Chromatography A · doi:10.1016/j.chroma.2026.467244 · Cited by 1
Artificial intelligence in the rational design of lipid nanoparticles for mRNA therapeutics
Zhao, H., Xu, J., Gao, X., Zhu, J., & He, Z. (2026) · The Innovation Drug Discovery · doi:10.59717/j.xinn-drugdisc.2026.100006 · Cited by 5
Electrostatically‐Stabilized PEG‐Free Lipid Nanoparticles for Systemic Nucleic Acid Delivery
Nabar, N., Kumaresh, D., Bueno, E. N., Pryor, M. L., & Hammond, P. T. (2026) · Advanced Functional Materials · doi:10.1002/adfm.77082 · Cited by 1
Park, J. S., Cho, B., Lim, S. G., Lee, Y., Jeon, H., Kim, I., Choi, H., & Koo, H. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124531 · Cited by 1
Structural evolution of ionizable lipids for nucleic acid delivery
Xue, L., Ang, M. J. Y., Swingle, K. L., Fitzgerald, E., Chalom, O. Z., Gu, N., & Mitchell, M. J. (2026) · Nature Reviews Chemistry · doi:10.1038/s41570-026-00865-0 · Cited by 2
Future of Medicinal Chemistry: Next-Generation Therapeutics
Tsomaia, N., Ufret, M. D. L., Bhat, A., & Nakhlé, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12294-2 · Cited by 2
Advances in mRNA Delivery and Clinical Applications
Hu, B., Hussain, A., Liu, Q. L., Weng, Y., & Huang, Y. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_13 · Cited by 1
Reversible, Covalent DNA Condensation Approach Using Chemical Linkers for Enhanced Gene Delivery
Wang, W., Tasset, A., Pyatnitskiy, I., Lin, P., Bellamkonda, A., Mehta, R., Gabbert, C., Yuan, F., Mohamed, H. G., Peppas, N. A., et al. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c02429 · Cited by 1
Self-citationCOVID-19 and progress in therapeutic approaches: a narrative review
Ilyas, U., Jadoon, S. S., Ahmed, T., Altaf, R., Khan, A., Ahmad, A., Rasool, Y., Masaud, S. M., & Khan, Z. (2024) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1394329 · Cited by 1
A Forecast of Targeting Leukemia Stem Cells by Nanomedicine
Huang, X., Kang, X., & Zhao, M. L. (2017) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000385 · Cited by 1
Recent Targeted of siRNA Delivery Vehicles for Cancer Therapy
Madkour, L. H. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.34.005577 · Cited by 1
Delivery of Genes and Oligonucleotides
Roth, C. M. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch25 · Cited by 1
Werfel, T. A. (2017) · Cited by 1
Hydrophobic Modification of siRNA to Improve Delivery and Efficacy of RNAi Therapeutics
Sarett, S. M. (2017) · Cited by 1
Ali, Y., Galbraith, T., Abdelfattah, N., Žiemys, A., Wong, T. L., Hashimoto, C., Faisal, M., Xu, Q., Cook, H., Pandita, T. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661471 · Cited by 1
COMBATING β-CATENIN DRIVEN HEPATOCELLULAR CARCINOMA
Delgado, E. R. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
RNA Interference-weapon against cancer
Verma, S., & Pandey, A. K. (2015) · Pharmatutor
Kumar, S. (2017) · MOJ Bioequivalence & Bioavailability · doi:10.15406/mojbb.2017.03.00032
Editor’s choice: recent research highlights from the International Journal of Nanomedicine
Shiekh, F. A., Abu-Izzah, A. M., Lee, V. J. Q., & Mudassar, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140083
Lipid nanoparticles for delivery of nucleic acid therapeutics
Chen, S. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0307282
Effect of mannose modified chitosan on uptake of nanoparticles by macrophagesPreprint
Lowsberg, D., & Smith, J. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/620906
Delivery and Formulation Methods for Therapeutic Genome Editing
Blenke, E. O., & Krishnamurthy, V. R. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch18
Role of protein corona on tumor-targeted delivery of DsiRNA using liquid nanoparticles
Chen, D. (2019) · Digital Repository Service (Northeastern University) · doi:10.17760/d20356166
Self-citationEngineering of Ionizable Lipid Nanoparticle for Efficient Crispr-Cas9 Delivery and Genome EditingPreprint
Sun, Q., Zhang, H., Ding, F., Zhu, Z., & Yang, C. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4476006
Application of Nanotherapeutics in Cancer Treatment
Johari, A., Chhabra, P., & Tripathy, D. B. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815256505124010008
Zhang, Z., Han, F., Lihe, H., Lu, L., Xiong, Q., Kang, X., Pan, D., Luo, Z., Lu, J., Lu, W., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907727
Have we finally found the ideal nucleic acid carrier with lipo-xenopeptides?
Wagner, E. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2586170
Tang, C., Ye, Y. H., Du, Y., Sun, Y., Su, R., Qi, W., & Wang, Y. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00656b
Ferrocene-contained cationic lipids via Ugi reaction for gene delivery and tumor cell ferroptosis
Wang, R., Tian, X., Li, J., Chen, J., Hu, Y., & Zhang, J. (2026) · Journal of Materials Science · doi:10.1007/s10853-026-12175-3
Advanced lipid nanoparticles for targeted nucleic acid delivery
Deng, Y., Chen, M., Zhou, X., Luo, T., Guo, J., Giles, A., Mourin, T. T., & Chen, G. (2026) · Nano Research · doi:10.26599/nr.2026.94908809
Cell‑intrinsic mechanisms underlying species differences in lipid nanoparticle‑mRNA deliveryPreprint
Goihberg, P., Martyniak, K., Hickey, J., Jami‐Alahmadi, Y., Soo, P. L., Narula, J., & Neubert, H. (2026) · Research Square · doi:10.21203/rs.3.rs-9180848/v1
Delivering base editors to the lungs
Cao, D., & Dong, Y. (2026) · Nature Materials · doi:10.1038/s41563-026-02602-w
Self-citationInnovative mucosal nanocarrier systems for enhanced immune response against respiratory pathogens
Zhang, Z., Chen, R., Zhou, X., (30400), H. W., Gong, H., Wang, C., Hao, R., Yuan, T., Hao, F., Xiong, Q., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.06.002
Aschmann, D., Knol, R. A., Verbeet, W., Wijngaarden, S., Escalona-Rayo, O., Freire, R. V. M., Bertram, K., Tekkali, I., Bunzel, G., Fontein, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.05.730351
Self-citationRancz, A., Schlagnitweit, J., Akrial, S.-E., Gajan, D., Gayet, L., Duong, N. T., Richert, L., Chami, M., Lollo, G., Peral, F., et al. (2026) · Small Methods · doi:10.1002/smtd.70797
Sriram, V., Phatangare, V., & Lee, J. (2026) · Biomaterials Science · doi:10.1039/d6bm00568c
RNA Size and Structure Modulate the Apparent p K a of Ionizable Lipid Nanoparticles
Priss, A., Lytvynenko, O., Vaněk, V., Sedlák, F., Šašková, K. G., & Cígler, P. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00177 · Cited by 1
Synthesis and optimization of ionizable lipids for RNA delivery
Wu, B., Lu, X., Padilla, M. S., Dharmesh, E., Xu, Y., Mitchell, M. J., & Han, X. (2026) · Chem · doi:10.1016/j.chempr.2026.103244
Brain-informed helper lipid selection enhances intracranial mRNA delivery
Cheung, K., Williams, M. A. C., Wu, Z., Liu, D., Wang, S. X., McHugo, B., Gona, P., Li, A., Baktir, B., Rao, S., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100616
Metadata
- Authors
- Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., Alabi, C. A., Sahay, G., Olejnik, K. T., Wang, W., Schroeder, A., Lytton-Jean, A. K. R., Siegwart, D. J., Akinc, A., Barnes, C., Barros, S. A., Carioto, M., Fitzgerald, K., Hettinger, J., Kumar, V., Novobrantseva, T. I., Qin, J., Querbes, W., Koteliansky, V., Langer, R., & Anderson, D. G.
- Affiliations
- Boston Children's Hospital (US)
- Massachusetts Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;
- Alnylam Pharmaceuticals (United States) (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-02-10
- Volume
- 111
- Issue
- 11
- Pages
- 3955-3960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3964096
- OpenAlex
- W2071030419
- Cited by
- 488
- References
- 35
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 53 · 2023: 51 · 2022: 40 · 2021: 42 · 2020: 35 · 2019: 30 · 2018: 29 · 2017: 39 · 2016: 41 · 2015: 36 · 2014: 17
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-03-26)
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Alnylam Pharmaceuticals
- National Institutes of Health (5r01de016516-10, 4r37eb000244-34, 5-R01-, 1f32eb017625-01, 5r01ca132091-04, CA151884, DE-016516, U54-CA151884, EB-000244, R01-EB000244-27, DE016516-03)
- National Heart, Lung, and Blood Institute (HHSN268201000045C)
- National Cancer Institute (5-R01-CA132091–04, U54CA151884, CA151884, R01-CA132091)
- National Institute of Biomedical Imaging and Bioengineering (R01-EB000244-27, EB-000244, R01EB000244, R37-EB000244, 1F32EB017625, F32 EB017625)
- National Institute of Dental and Craniofacial Research (R01DE016516-03)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- siRNA delivery, apolipoprotein E, hepatocyte targeting, liver parenchymal cells, siRNA therapeutics, toxicity, rodents, non-human primates, lipoproteins
- MeSH terms
- Animals, Apolipoproteins E, Macaca fascicularis, Drug Delivery Systems, Cryoelectron Microscopy, Gene Silencing, Hepatocytes, RNA, Small Interfering, Mice, Rats, Nanoparticles, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
